 |
 |
Read
more than 4,000 books online FREE! More than 1900 PDFs now available
for sale |
|
|
|
 |
Questions? Call 888-624-8373 |
 |
|
Orphans and Incentives:
Developing Technology to Address Emerging Infections
|
|
Status: Available Now
Size: 112 pages, 6 x 9
Publication Year:1997
|
|
|
| Print |
List Price |
Your Price |
|
 |
PAPERBACK
ISBN-10: 0-309-05941-0
ISBN-13: 978-0-309-05941-1
|
$25.00 |
$22.50 |
Add to Cart |
|
Authors:
Polly F. Harrison and Joshua Lederberg, Editors; Forum on Emerging Infections, Institute of Medicine Authoring Organizations
Description: Infectious diseases remain a leading cause of prolonged illness, premature mortality, and soaring health costs. In the United States in 1995, infectious diseases were the third leading cause of death, right behind heart disease and cancer. Mortality is mounting over ... Read More
|
|
|
Full Text
Jump to this book's table of contents to begin reading online for free.
|
Web Search Builder
Use this book's key terms to search within this book, across our
collection, or across the Web.
Reference
Finder
Paste in your own text to find books that relate to your topic.
|
|
Description
Infectious diseases remain a leading cause of prolonged illness, premature mortality, and soaring health costs. In the United States in 1995, infectious diseases were the third leading cause of death, right behind heart disease and cancer. Mortality is mounting over time, owing to HIV/AIDS, pneumonia, and septicemia, with drug resistance playing an ever-increasing role in each of these disease categories. This book, a report from a Forum on Emerging Infections workshop, focuses on product areas where returns from the market might be perceived as being too small or too complicated by other factors to compete in industrial portfolios with other demands for investment. Vaccines are quintessential examples of such products. The lessons learned fall into four areas, including what makes intersectoral collaboration a reality, the notion of a product life cycle, the implications of divergent sectoral mandates and concepts of risk, and the roles of advocacy and public education. The summary contains an examination of the Children's Vaccine Initiative and other models, an industry perspective on the emerging infections agenda, and legal and regulatory issues.
About the PDF: What am I Buying?
About Our PDFs
This book can be purchased as a computer file. The format of the file is called a "PDF". To open, view and print the file, you must have third party software (e.g. Adobe Reader or XPDF) installed on your computer.
Benefits of Buying a PDF
-
Instant. Buy it, download it immediately, and start reading.
-
Convenient. Download it to your laptop and read it whenever, wherever.
-
Searchable. Search for any word or phrase.
What are my options?
| If you want ...
| Then ...
|
| ... a computer file containing the entire book |
... buy a PDF |
| ... to read the book immediately and also own a copy for your bookshelf |
... buy the bundle |
| ... a copy for your bookshelf |
... buy the book |
Will my PDF be emailed to me?
No. After buying the PDF, we will email you instructions on how to download the file from our Web site. The PDF file will not be emailed to you.
See our Frequently Asked Questions for more information including:
|
SIGN UP FOR...
New Title Emails
Read about the newest releases and receive special offers.
|
|
|